A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

January 18, 2023

Primary Completion Date

September 30, 2029

Study Completion Date

September 30, 2029

Conditions
Multifocal Motor Neuropathy (MMN)
Interventions
BIOLOGICAL

ARGX-117

Intravenous administration of ARGX-117

OTHER

Placebo

Intravenous administration of placebo

Trial Locations (27)

1090

Medizinische Universitat Wien (Medical University of Vienna), Vienna

9000

AZ Sint-Lucas, Ghent

19104

University of Pennsylvania - Perelman Center for Advanced Medicine, Philadelphia

20089

IRCCS Humanitas Research Hospital, Rozzano

20132

IRCCS Ospedale San Raffaele S.r.l., Milan

33076

CHU Bordeaux - Groupe Hospitalier Pellegrin, Bordeaux

37075

Universitatsmedizin Gottingen (UMG) Georg-August-Universitaet, Göttingen

44195

The Cleveland Clinic Foundation, Cleveland

45147

Universitätsklinikum Essen, Essen

46026

Hospital Universitari i Politecnic La Fe de Valencia, Valencia

55414

University of Minnesota, Minneapolis

56126

Azienda Ospedaliero Universitaria Pisana, Pisa

59037

Hôpital Roger Salengro (CHU de Lille), Lille

60026

NorthShore University HealthSystem, Glenview

75651

Hôpital de la Pitié Salpétrière, Paris

78759

Austin Neuromuscular Center, Austin

85251

HonorHealth Neurology, Scottsdale

Unknown

University Health Network, Toronto

06001

CHU de Nice, Nice

00189

Azienda Ospedaliera Sant' Andrea, Rome

3584 CX

Universitair Medisch Centrum Utrecht, Utrecht

31-426

Michalski i Partnerzy Lekarze Spolka Partnerska, Krakow

02-097

Warszawski Uniwersytet Medyczny, Warsaw

08035

Hospital Universitario Vall d'Hebron, Barcelona

08041

Hospital de La Santa Creu i Sant Pau, Barcelona

G51 4TF

Queen Elizabeth University Hospital, Glasgow

OX3 9DU

Oxford University Hospitals NHS Trust, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

argenx

INDUSTRY

NCT05405361 - A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy | Biotech Hunter | Biotech Hunter